Gideon Strategic Partners
VC Fund
Santa Monica, United States
Gideon Strategic Partners is a VC fund in Santa Monica focused on Medical and Medical Device. Gideon Strategic Partners specializes in asset management, risk management, financial, estate and retirement planning services.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Gideon Strategic Partners invests in
Stages Gideon Strategic Partners invests in
Countries Gideon Strategic Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ed Kispert
|
|||
Robert D. Amoruso
|
|||
Investment Focus
Industry
- Medical 2 (40%)
- Medical Device 2 (40%)
- RFID 1 (20%)
- Retail 1 (20%)
- Wireless 1 (20%)
Stage
- Series C 2 (40%)
- Series B 1 (20%)
Country
- United States 2 (40%)
- France 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ed Kispert
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 0 | Find email | |
|
Robert D. Amoruso
CEO & Managing Partner
|
CEO & Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
RADAR
|
RADAR is a platform that combines RFID and computer vision to automate and augment retail store processes. Our technology offers unprecedented speed and location accuracy, which allows stores to: 1) Manage inventory efficiently through automated inventory counts, improved in-store replenishment, and instantaneous customer stock checks. 2) Measureall customer-product interactions, giving physical stores the same insight into consumer behavior and product performance as online stores. 3) Eliminate checkout lines altogether through our autonomous checkout tool.RADAR was founded in 2013 and is headquartered in New York, NY, USA. | $170M / Series B / May 19, 2026 | |
SafeHeal
|
SafeHeal is the first company created and incubated by MD Start, a medtech accelerator developing innovative medical devices based on inventions from physicians. It is currently funded by MD Start and Sofinnova Partners. SafeHeal is laureate of the Worldwide Innovation Challenge 2015 edition (Concours Mondial de l’Innovation - Phases 1 and 2) andof the iLab grant program, which foster talent and bring out future champions of the French economy.SafeHeal was also elected as the most promising and innovative investor conference MedTech start-up at Biovision 2016, was a finalist for the global Medtech Innovator 2016 competition.Finally, SafeHeal is a 2016 recipient of the Charles Foix grant which rewards innovations aimed at improving the quality of life of elderly people. | $11.7M / Series C / Sep 10, 2025 | |
|
SafeHeal
|
SafeHeal is the first company created and incubated by MD Start, a medtech accelerator developing innovative medical devices based on inventions from physicians. It is currently funded by MD Start and Sofinnova Partners. SafeHeal is laureate of the Worldwide Innovation Challenge 2015 edition (Concours Mondial de l’Innovation - Phases 1 and 2) andof the iLab grant program, which foster talent and bring out future champions of the French economy.SafeHeal was also elected as the most promising and innovative investor conference MedTech start-up at Biovision 2016, was a finalist for the global Medtech Innovator 2016 competition.Finally, SafeHeal is a 2016 recipient of the Charles Foix grant which rewards innovations aimed at improving the quality of life of elderly people. | $39.9M / Series C / Apr 29, 2025 | |
Capstan Medical
|
Capstan Medical is creating minimally invasive technologies to treat heart valve disorders. | $110M / Series C / Dec 11, 2024 | |
Osteal Therapeutics
|
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $50M / Series D / Jun 05, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Gideon Strategic Partners invest in?
Gideon Strategic Partners invests primarily in Medical, Medical Device and RFID startups, most often at Series C and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gideon Strategic Partners?
Public channels for Gideon Strategic Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Gideon Strategic Partners?
The team at Gideon Strategic Partners includes Ed Kispert (Founder & Managing Partner) and Robert D. Amoruso (CEO & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
